AVE 0.00% 0.3¢ avecho biotechnology limited

Ann: Phosphagenics Receives Arbitration Update from SIAC, page-235

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 650 Posts.
    lightbulb Created with Sketch. 78
    Playez you haven't debated HT at any time, you've just posted negative, unsupported opinions, without fact and HT has merely debunked your tirade time and time again.

    Esra threw the proverbial spanner in the works, it was always going to take time to heal from that. The market slammed POH for ages and we now are seeing a lift in sentiment based on a deal with TPM technology applied to daptomycin that was so tempting that our original partner allegedly attempted to unjustly enrich themselves from.

    The market seems to think that POH will be successful in defending its patent and getting compensation based on recent price action from a low of $0.005 to $0.023...maybe you have conveniently not noticed that! And once the alleged wrong in regard to daptomycin is rectified the door then is firmly open to some serious deals from other injectible candidates.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.